Top Markets
#1 Smilek to the Bank Smilek to the Bank +50.56%
#2 Purr Purr +47.15%
#3 Pons Pons +44.66%
#4 Non-Playable Coin Non-Playable Coin +28.34%
#5 StonkBroker StonkBroker +24.99%
#6 Kinetiq Kinetiq +24.50%
#7 ApeX ApeX +24.20%
#8 OriginTrail OriginTrail +19.97%
#9 Pudgy Penguins Pudgy Penguins +19.48%
#10 Grass Grass +19.15%
Coin of the day
Smilek to the Bank Smilek to the Bank
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Kinnate Biopharma Inc. Kinnate Biopharma Inc.

Kinnate Biopharma Inc.

KNTE
Classificação em ações #21071
Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily... Kinnate Biopharma Inc. is a U.S.-based biopharmaceutical company primarily focused on identifying and advancing small-molecule drugs that target kinase enzymes to treat cancers defined by specific genetic markers. The company's product pipeline includes: KIN-2787: An inhibitor of rapidly accelerated fibrosarcoma (RAF), currently being developed to treat patients with lung cancer, melanoma, and other forms of solid tumors. KIN-3248: A small-molecule kinase inhibitor designed to counteract cancer-associated genetic mutations in the fibroblast growth factor receptors, specifically FGFR2 and FGFR3. KIN004 Program: This program encompasses early-stage small-molecule research, including a Cyclin-Dependent Kinase 12 (CDK12) inhibitor. Established in 2018, Kinnate Biopharma Inc. maintains its headquarters in San Francisco, California. It was formerly a division of Fount Therapeutics, LLC.
Preço da ação
$2.65
Última sincronização: 2024-04-03
Valor de mercado
$115.71M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Kinnate Biopharma Inc. (KNTE)

Categoria

Healthcare
Preço KNTE com a capitalização de mercado de B
Kinnate Biopharma Inc. Kinnate Biopharma Inc.
KNTE
$2.65
Capitalização de mercado de Kinnate Biopharma Inc.(KNTE)
Valor de mercado: $115.71M
Em August 2026, Kinnate Biopharma Inc. tem uma capitalização de mercado de $115.71M. Isso faz com que Kinnate Biopharma Inc. seja a 21071st empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Kinnate Biopharma Inc. de 2020 a 2026
KNTE comparado com o topo de 5 mais populares stocks
Preço para KNTE Ativo B Capitalização de mercado de B Resultados
Kinnate Biopharma Inc. Kinnate Biopharma Inc.
$119,352 $115.71M
NVIDIA Corporation NVIDIA Corporation
NVDA
$5.211T +4,503,754.68%
Kinnate Biopharma Inc. Kinnate Biopharma Inc.
$104,131 $115.71M
Apple Inc. Apple Inc.
AAPL
$4.547T +3,929,363.38%
Kinnate Biopharma Inc. Kinnate Biopharma Inc.
$95,330.13 $115.71M
Alphabet Inc. Alphabet Inc.
GOOG
$4.162T +3,597,263.24%
Kinnate Biopharma Inc. Kinnate Biopharma Inc.
$82,283.04 $115.71M
Microsoft Corporation Microsoft Corporation
MSFT
$3.593T +3,104,920.52%
Kinnate Biopharma Inc. Kinnate Biopharma Inc.
$63,962.69 $115.71M
Amazon.com, Inc. Amazon.com, Inc.
AMZN
$2.793T +2,413,586.36%